Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder

Effect of Pantogam active subchronic administration (200 mg/kg/day, i.p.) on the behavior of outbred CD-1 mice in the experimental model of attention deficit disorder was studied in the "closed enriched cross maze" test. Pantogam active corrected the initial attention deficit of ED-low rod...

Full description

Saved in:
Bibliographic Details
Main Authors: N. A. Sukhorukova, E. V. Vasileva, E. A. Kondrakhin, R. M. Salimov, G. I. Kovalev
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2022-07-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/315
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248667015315456
author N. A. Sukhorukova
E. V. Vasileva
E. A. Kondrakhin
R. M. Salimov
G. I. Kovalev
author_facet N. A. Sukhorukova
E. V. Vasileva
E. A. Kondrakhin
R. M. Salimov
G. I. Kovalev
author_sort N. A. Sukhorukova
collection DOAJ
description Effect of Pantogam active subchronic administration (200 mg/kg/day, i.p.) on the behavior of outbred CD-1 mice in the experimental model of attention deficit disorder was studied in the "closed enriched cross maze" test. Pantogam active corrected the initial attention deficit of ED-low rodents subpopulation without changing other parameters of their behavior. Analysis of the results of radioligand binding revealed statistically significant differences in the distribution of D2 and GABAB-receptors in the brain structures of outbred CD-1 mice subpopulations. In the prefrontal cortex (PFC) of ED-low control group with reduced attention level, compared with ED-high control, density of D2 receptors was higher by 18 %, while density of GABAB receptors was lower by 35 %. Administration of pantogam active resulted in decreasing of D2 receptors density by 23 % and increasing of this indicator by 42 % for GABAB- receptors in the PFC of ED-low animals, respectively. Thus, this studied drug has potential efficacy in treating attention deficit in experimental animals, normalizes behavior and possible molecular markers of this pathology.
format Article
id doaj-art-9feb8249b1df4ea985fe39d2ebae4d74
institution Kabale University
issn 2587-7836
2686-8830
language Russian
publishDate 2022-07-01
publisher LLC “Publisher OKI”
record_format Article
series Фармакокинетика и Фармакодинамика
spelling doaj-art-9feb8249b1df4ea985fe39d2ebae4d742025-08-20T03:57:48ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302022-07-0102233010.37489/2587-7836-2022-2-23-30301Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorderN. A. Sukhorukova0E. V. Vasileva1E. A. Kondrakhin2R. M. Salimov3G. I. Kovalev4FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”Effect of Pantogam active subchronic administration (200 mg/kg/day, i.p.) on the behavior of outbred CD-1 mice in the experimental model of attention deficit disorder was studied in the "closed enriched cross maze" test. Pantogam active corrected the initial attention deficit of ED-low rodents subpopulation without changing other parameters of their behavior. Analysis of the results of radioligand binding revealed statistically significant differences in the distribution of D2 and GABAB-receptors in the brain structures of outbred CD-1 mice subpopulations. In the prefrontal cortex (PFC) of ED-low control group with reduced attention level, compared with ED-high control, density of D2 receptors was higher by 18 %, while density of GABAB receptors was lower by 35 %. Administration of pantogam active resulted in decreasing of D2 receptors density by 23 % and increasing of this indicator by 42 % for GABAB- receptors in the PFC of ED-low animals, respectively. Thus, this studied drug has potential efficacy in treating attention deficit in experimental animals, normalizes behavior and possible molecular markers of this pathology.https://www.pharmacokinetica.ru/jour/article/view/315attention deficit disorderpantogam activeclosed enriched cross mazeradioligand bindingd<sub>2</sub> receptorgaba<sub>b</sub>-receptornmda receptorexploratory behaviorprefrontal cortex
spellingShingle N. A. Sukhorukova
E. V. Vasileva
E. A. Kondrakhin
R. M. Salimov
G. I. Kovalev
Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder
Фармакокинетика и Фармакодинамика
attention deficit disorder
pantogam active
closed enriched cross maze
radioligand binding
d<sub>2</sub> receptor
gaba<sub>b</sub>-receptor
nmda receptor
exploratory behavior
prefrontal cortex
title Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder
title_full Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder
title_fullStr Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder
title_full_unstemmed Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder
title_short Effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder
title_sort effects of pantogam active on behavior and neuroreceptor spectrum in mouse model of attention deficit disorder
topic attention deficit disorder
pantogam active
closed enriched cross maze
radioligand binding
d<sub>2</sub> receptor
gaba<sub>b</sub>-receptor
nmda receptor
exploratory behavior
prefrontal cortex
url https://www.pharmacokinetica.ru/jour/article/view/315
work_keys_str_mv AT nasukhorukova effectsofpantogamactiveonbehaviorandneuroreceptorspectruminmousemodelofattentiondeficitdisorder
AT evvasileva effectsofpantogamactiveonbehaviorandneuroreceptorspectruminmousemodelofattentiondeficitdisorder
AT eakondrakhin effectsofpantogamactiveonbehaviorandneuroreceptorspectruminmousemodelofattentiondeficitdisorder
AT rmsalimov effectsofpantogamactiveonbehaviorandneuroreceptorspectruminmousemodelofattentiondeficitdisorder
AT gikovalev effectsofpantogamactiveonbehaviorandneuroreceptorspectruminmousemodelofattentiondeficitdisorder